Clinical Trials on Primary or Secondary Prophylactic Treatment in Liechtenstein
Total 1 results
-
Ivoclar Vivadent AGRecruitingInsufficient Dental Filling or Primary Caries (Class I or II Cavities in Premolars or Molars)Liechtenstein
Sponsors and Collaborators
- American Association of Critical Care Nursing
- REDNVIA Co., Ltd.
- Instituto National de Edfermedades Neoplasicas
- Kingston Hospital NHS Trust
- Progenics Pharmaceuticals, Inc.
- Johan Sanmartin Berglund
- Dr. med. Christian Rothermundt
- Laboratoire de la Mer
- Adial Pharmaceuticals
- Natalis Counseling Center
- Luiz Aparecido Bortolotto
- Hospital Central de San Isidro Dr. Melchor Angel Posse
- Shu Mei Kato
- Kyowa Hakko Bio Co., Ltd.
- Dawn Smiley MD
- Healthy African American Families II
- Heba Mitwalli
- Sinomune Pharmaceutical Co., Ltd
- Ningbo Medical Center Lihuili Eastern Hospital
- Hospital Clinico Universitario de Santiago
- View Full List
Medical Conditions
- Hormone Sensitive Prostate Cancer
- Intestinal Edema
- Patients With Diagnosed Malignancies Being Considered for Clinical Trials
- Hot Flash Due to Medication
- Cytochrome P450 Phenotype and Genotype Metrics
- Recurrent Extragonadal Germ Cell Tumor
- Bloodstream Infection (BSI)
- Stage IIB Soft Tissue Sarcoma AJCC v7
- Dental Implant Failed
- Intraoperative Parathyroid Scores System
- Reduction in Bacterial Counts Through the Use of Mouthwash
- Upper Gastrointestinal Lesions
- Sperm Count, Low
- HR-positive, HER2-low Breast Cancer
- Mental Abuse of Adult
- Long-term Venous Access
- Mitral Valve Surgery
- Respiratory Rate Accuracy Test
- Deep Sedation Additional Time Required for Volatile Sedation Afer Free Flap Surgery
- Early Onset Preeclampsia
- View Full List
Drug Interventions
- CKD-501 and D759
- Probiotic
- Apatinib Mesylate
- Endocrine Therapy
- Janssen Ad26.COV2.S
- Insulin-like growth factor I
- PERSERIS
- Naproxen
- Pembrolizumab
- Carboplatin
- Teniposide
- 0.9% NS + AT
- Standard treatment+mirabegron
- BI 207127
- REGN3500
- Finasteride
- Antiplatelet Drug (Aspirin or Statin)
- Sintilimab
- Acalabrutinib in combination with VR
- Trastuzumab deruxtecan (T-DXd) with pyrotinib
- View Full List
CROs by country
- Contract Research Organizations in Bangladesh
- Contract Research Organizations in Bosnia & Herzegovina
- Contract Research Organizations in Congo, DR of
- Contract Research Organizations in Denmark
- Contract Research Organizations in Lithuania
- Contract Research Organizations in Moldova
- Contract Research Organizations in Mozambique
- Contract Research Organizations in Norway
- Contract Research Organizations in Papua New Guinea
- Contract Research Organizations in Paraguay
- Contract Research Organizations in Philippines
- Contract Research Organizations in Portugal
- Contract Research Organizations in Ukraine
- CRO list by country